Hemoglobin S antigelation agents based on 5-bromotryptophan with potential for sickle cell anemia

Philomen Z. De Croos, Puckprink Sangdee, Brenda L. Stockwell, Leela Kar, Emmanuel B. Thompson, Michael E. Johnson, Bruce L. Currie

Journal of Medicinal Chemistry · 1990 · 19 citations · 0 references

Concepts

Abstract

5-Bromotryptophan (5-BrTrp) is the most potent amino acid derivative reported in the literature to inhibit the gelation of hemoglobin S (from sickle cell anemia patients). Trp-Trp is also more potent than Trp as an antigelation agent. Therefore, we have prepared a series of dipeptides containing 5-BrTrp and evaluated the antigelation activity. 5-BrTrp-5-BrTrp is the most potent, i.e., 5.9 times the activity of Trp, followed by 5-BrTrp-Trp and then Trp-5-BrTrp. This improved antigelation potency for 5-BrTrp-5-BrTrp and 5-BrTrp-Trp is very significant and will be pursued further as lead compounds with potential for sickle cell anemia.